cagrilintide clinical trials is an investigational, long-acting amylin analog. Amylin is a hormone released with insulin after meals. By mimicking some of its effects, cagrilintide may reduce appetite, slow gastric emptying, and influence post-meal Select Box Quantity:1 Box Eye Area Obesity and Pancreatic Cancer:

cagrilintide clinical trials is an investigational, long-acting amylin analog. Amylin is a hormone released with insulin after meals. By mimicking some of its effects, cagrilintide may reduce appetite, slow gastric emptying, and influence post-meal Select Box Quantity:1 Box Eye Area Obesity and Pancreatic Cancer:

Obesity and Pancreatic Cancer: Its Role in Oncogenesis | IntechOpen

The most commonly reported side effects are mild injection site reactions, occasional headache, and transient nausea

Eye Area

Select Box Quantity:1 Box

Neuroimaging data have revealed that diabetes patients often present with white matter damage and reduced brain volumes, which may be a consequence of BBB injury [3]